Literature DB >> 30450325

Comment on "Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration".

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Entities:  

Year:  2018        PMID： 30450325      PMCID： PMC6232321          DOI： 10.18240/ijo.2018.11.25

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  15 in total

1.  CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE: The TWIN Study.

Authors:  Eric H Souied; Hassiba Oubraham; Gérard Mimoun; Salomon Y Cohen; Stéphane Quere; Audrey Derveloy
Journal:  Retina       Date:  2015-09       Impact factor: 4.256

2.  Long-term Outcomes of Aflibercept Treatment for Neovascular Age-related Macular Degeneration in a Clinical Setting.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Am J Ophthalmol       Date:  2016-12-23       Impact factor: 5.258

3.  High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-08       Impact factor: 3.117

4.  Comments to: Visual and anatomic outcomes after conversion to aflibercept in neovascular age-related macular degeneration: 12-month results.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Eur J Ophthalmol       Date:  2017-06-26       Impact factor: 2.597

5.  Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Am J Ophthalmol       Date:  2016-12-05       Impact factor: 5.258

6.  Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration.

Authors:  Bekir Küçük; Sibel Kadayıfçılar; Bora Eldem
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

7.  Macular and retinal nerve fiber layer thickness in Japanese measured by Stratus optical coherence tomography.

Authors:  Toshiyuki Oshitari; Katsuhiro Hanawa; Emiko Adachi-Usami
Journal:  Clin Ophthalmol       Date:  2007-06

8.  Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).

Authors:  Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal:  Am J Ophthalmol       Date:  2009-05-09       Impact factor: 5.258

9.  Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study.

Authors:  Salomon Y Cohen; Gerard Mimoun; Hassiba Oubraham; Alain Zourdani; Christian Malbrel; Stephane Queré; Véronique Schneider
Journal:  Retina       Date:  2013-03       Impact factor: 4.256

10.  Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.

Authors:  Akiyuki Kawamura; Mitsuko Yuzawa; Ryusaburo Mori; Miho Haruyama; Koji Tanaka
Journal:  Acta Ophthalmol       Date:  2013-07-15       Impact factor: 3.761
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.